Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions

Linda J. Titus, Lisa M. Reisch, Anna N.A. Tosteson, Heidi Nelson, Paul D. Frederick, Patricia (Patty) Carney, Raymond L. Barnhill, David E. Elder, Martin A. Weinstock, Michael W. Piepkorn, Joann G. Elmore

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives The impact of malpractice concerns on pathologists' use of defensive medicine and interpretations of melanocytic skin lesions (MSLs) is unknown. Methods A total of 207 pathologists interpreting MSLs responded to a survey about past involvement in malpractice litigation, influence of malpractice concerns on diagnosis, and use of assurance behaviors (defensive medicine) to alleviate malpractice concerns. Assurance behaviors included requesting second opinions, additional slides, additional sampling, and ordering specialized tests. Results Of the pathologists, 27.5% reported that malpractice concerns influenced them toward a more severe MSL diagnosis. Nearly all (95.2%) pathologists reported practicing at least one assurance behavior due to malpractice concerns, and this practice was associated with being influenced toward a more severe MSL diagnosis (odds ratio, 2.72; 95% confidence interval, 1.41-5.26). Conclusions One of four US skin pathologists upgrade MSL diagnosis due to malpractice concerns, and nearly all practice assurance behaviors. Assurance behaviors are associated with rendering a more severe MSL diagnosis.

Original languageEnglish (US)
Pages (from-to)338-345
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume150
Issue number4
DOIs
StatePublished - Aug 30 2018

Fingerprint

Defensive Medicine
Malpractice
Skin
Jurisprudence
Referral and Consultation
Odds Ratio
Pathologists
Confidence Intervals

Keywords

  • Assurance behaviors
  • Defensive medicine
  • Diagnosis
  • Medical malpractice
  • Melanocytic skin lesions
  • Melanoma
  • Skin pathology

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions. / Titus, Linda J.; Reisch, Lisa M.; Tosteson, Anna N.A.; Nelson, Heidi; Frederick, Paul D.; Carney, Patricia (Patty); Barnhill, Raymond L.; Elder, David E.; Weinstock, Martin A.; Piepkorn, Michael W.; Elmore, Joann G.

In: American Journal of Clinical Pathology, Vol. 150, No. 4, 30.08.2018, p. 338-345.

Research output: Contribution to journalArticle

Titus, LJ, Reisch, LM, Tosteson, ANA, Nelson, H, Frederick, PD, Carney, PP, Barnhill, RL, Elder, DE, Weinstock, MA, Piepkorn, MW & Elmore, JG 2018, 'Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions', American Journal of Clinical Pathology, vol. 150, no. 4, pp. 338-345. https://doi.org/10.1093/ajcp/aqy057
Titus, Linda J. ; Reisch, Lisa M. ; Tosteson, Anna N.A. ; Nelson, Heidi ; Frederick, Paul D. ; Carney, Patricia (Patty) ; Barnhill, Raymond L. ; Elder, David E. ; Weinstock, Martin A. ; Piepkorn, Michael W. ; Elmore, Joann G. / Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions. In: American Journal of Clinical Pathology. 2018 ; Vol. 150, No. 4. pp. 338-345.
@article{c0bcf9eb25044b3aaabab59712e45418,
title = "Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions",
abstract = "Objectives The impact of malpractice concerns on pathologists' use of defensive medicine and interpretations of melanocytic skin lesions (MSLs) is unknown. Methods A total of 207 pathologists interpreting MSLs responded to a survey about past involvement in malpractice litigation, influence of malpractice concerns on diagnosis, and use of assurance behaviors (defensive medicine) to alleviate malpractice concerns. Assurance behaviors included requesting second opinions, additional slides, additional sampling, and ordering specialized tests. Results Of the pathologists, 27.5{\%} reported that malpractice concerns influenced them toward a more severe MSL diagnosis. Nearly all (95.2{\%}) pathologists reported practicing at least one assurance behavior due to malpractice concerns, and this practice was associated with being influenced toward a more severe MSL diagnosis (odds ratio, 2.72; 95{\%} confidence interval, 1.41-5.26). Conclusions One of four US skin pathologists upgrade MSL diagnosis due to malpractice concerns, and nearly all practice assurance behaviors. Assurance behaviors are associated with rendering a more severe MSL diagnosis.",
keywords = "Assurance behaviors, Defensive medicine, Diagnosis, Medical malpractice, Melanocytic skin lesions, Melanoma, Skin pathology",
author = "Titus, {Linda J.} and Reisch, {Lisa M.} and Tosteson, {Anna N.A.} and Heidi Nelson and Frederick, {Paul D.} and Carney, {Patricia (Patty)} and Barnhill, {Raymond L.} and Elder, {David E.} and Weinstock, {Martin A.} and Piepkorn, {Michael W.} and Elmore, {Joann G.}",
year = "2018",
month = "8",
day = "30",
doi = "10.1093/ajcp/aqy057",
language = "English (US)",
volume = "150",
pages = "338--345",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4",

}

TY - JOUR

T1 - Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions

AU - Titus, Linda J.

AU - Reisch, Lisa M.

AU - Tosteson, Anna N.A.

AU - Nelson, Heidi

AU - Frederick, Paul D.

AU - Carney, Patricia (Patty)

AU - Barnhill, Raymond L.

AU - Elder, David E.

AU - Weinstock, Martin A.

AU - Piepkorn, Michael W.

AU - Elmore, Joann G.

PY - 2018/8/30

Y1 - 2018/8/30

N2 - Objectives The impact of malpractice concerns on pathologists' use of defensive medicine and interpretations of melanocytic skin lesions (MSLs) is unknown. Methods A total of 207 pathologists interpreting MSLs responded to a survey about past involvement in malpractice litigation, influence of malpractice concerns on diagnosis, and use of assurance behaviors (defensive medicine) to alleviate malpractice concerns. Assurance behaviors included requesting second opinions, additional slides, additional sampling, and ordering specialized tests. Results Of the pathologists, 27.5% reported that malpractice concerns influenced them toward a more severe MSL diagnosis. Nearly all (95.2%) pathologists reported practicing at least one assurance behavior due to malpractice concerns, and this practice was associated with being influenced toward a more severe MSL diagnosis (odds ratio, 2.72; 95% confidence interval, 1.41-5.26). Conclusions One of four US skin pathologists upgrade MSL diagnosis due to malpractice concerns, and nearly all practice assurance behaviors. Assurance behaviors are associated with rendering a more severe MSL diagnosis.

AB - Objectives The impact of malpractice concerns on pathologists' use of defensive medicine and interpretations of melanocytic skin lesions (MSLs) is unknown. Methods A total of 207 pathologists interpreting MSLs responded to a survey about past involvement in malpractice litigation, influence of malpractice concerns on diagnosis, and use of assurance behaviors (defensive medicine) to alleviate malpractice concerns. Assurance behaviors included requesting second opinions, additional slides, additional sampling, and ordering specialized tests. Results Of the pathologists, 27.5% reported that malpractice concerns influenced them toward a more severe MSL diagnosis. Nearly all (95.2%) pathologists reported practicing at least one assurance behavior due to malpractice concerns, and this practice was associated with being influenced toward a more severe MSL diagnosis (odds ratio, 2.72; 95% confidence interval, 1.41-5.26). Conclusions One of four US skin pathologists upgrade MSL diagnosis due to malpractice concerns, and nearly all practice assurance behaviors. Assurance behaviors are associated with rendering a more severe MSL diagnosis.

KW - Assurance behaviors

KW - Defensive medicine

KW - Diagnosis

KW - Medical malpractice

KW - Melanocytic skin lesions

KW - Melanoma

KW - Skin pathology

UR - http://www.scopus.com/inward/record.url?scp=85054561440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054561440&partnerID=8YFLogxK

U2 - 10.1093/ajcp/aqy057

DO - 10.1093/ajcp/aqy057

M3 - Article

C2 - 30007278

AN - SCOPUS:85054561440

VL - 150

SP - 338

EP - 345

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4

ER -